If you liked this article you might like

Board Revised as Perrigo Settles With Activist Investor Starboard
Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
Dow's March to 20,000 Hits Another Snag as Crude Settles at Two-Week Low
Dow's Attempt at 20,000 Fades as Crude Reverses Course